Table 2 Sample description. Information on the healthy subjects (HS) and patients with SZ included in the neuroimaging association study. Sex description includes male:female count (frequency in males). The clinical description of patients includes Illness duration (in years), the PANSS scores, and chlorpromazine (CPZ) equivalent dose (mg/day). All the quantitative variables include the mean value and (standard deviation).

From: Combining fMRI and DISC1 gene haplotypes to understand working memory-related brain activity in schizophrenia

  

Healthy Subjects

Patients with SZ

 

Neuroimaging Association sample (HS:70, SZ:70)

Sex

48:22 (0.68)

48:22 (0.68)

χ2 = 0.00, p = 1

Age

38.86 (11.34)

39.05 (11.31)

U = 2433, p = 0.944

Estimated IQ (TAP)

103.03 (7.84)

102.03 (8.54)

U = 2282, p = 0.482

Illness durationa

–

15.93 (11.63)

–

PANSS Totalb

–

60.40 (30.85)

–

PANSS Positiveb

–

18.55 (6.01)

–

PANSS Negativeb

–

23.75 (8.57)

–

PANSS general psychopathologyb

–

30.22 (12.68)

–

CPZ equivalentsb

–

533.21 (433.93)

–

  1. aData of illness duration was available for 67 patients.
  2. bData of PANSS scores and CPZ equivalents were available for 65 patients.
Back to article page